Topic List : Cardiovascular Health
Moms’ blood sugar affects fetal heart
Elevated maternal blood sugar when the fetal heart is forming has been linked to a heightened risk for congenital heart defects, according to a new Stanford study.
Stanford to collaborate on Apple Heart Study
The study will make use of an app to determine whether the Apple Watch’s heart-rate sensor can help detect a heart condition known as atrial fibrillation.
Stafford on high blood pressure
Under the new guidelines, tens of millions more Americans now meet the criteria for having high blood pressure.
Study upends heart-valve replacement guidelines
The benefits of a mechanical valve compared with a biological valve persist until the age of 70 for mitral-valve replacement, according to a new Stanford study.
Team effort prevails against heart defect
A multidisciplinary care team at Packard Children’s Hospital ushered Kennedy Greenfield, hampered by a congenital heart defect, from the womb into the world.
Fixing hearts of infants with genetic defects
Infants with the genetic disorders trisomy 13 or 18 are more likely to survive if they undergo heart surgery, a study from researchers at Stanford and the University of Arkansas has found.
China-Stanford cardiovascular symposium
The two-day conference will create a platform for sharing heart disease expertise and knowledge between China and Stanford, and could set the stage for future collaborations.
Predicting, preventing a second stroke
Using health records, Stanford researchers developed an algorithm for scoring the risk of a stroke patient experiencing a heart condition known as atrial fibrillation, a major risk factor for a second stroke.
Cardiology care for A-fib linked to lower stroke risk
Patients with the irregular heart rhythm known as atrial fibrillation who got early cardiology care had a reduced risk of stroke, probably because they were more likely to be prescribed anticoagulants, Stanford researchers found.
New technology provides rare diagnosis
Stanford scientists have used a next-generation technology called long-read sequencing to diagnose a patient’s rare genetic condition that current technology failed to diagnose.